Two Sigma Investments, LP Allogene Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,712,139 shares of ALLO stock, worth $5.26 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,712,139
Previous 2,797,970
3.07%
Holding current value
$5.26 Million
Previous $7.83 Million
26.27%
% of portfolio
0.01%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding ALLO
# of Institutions
177Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$36.3 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$31.9 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$21.1 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$15.5 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$14.1 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $279M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...